Your browser doesn't support javascript.
loading
Clinical comprehensive evaluation for Chinese patent medicine based on evidence-based medicine and pharma- coeconomic model / 中国药房
China Pharmacy ; (12): 1870-1875, 2022.
Article in Chinese | WPRIM | ID: wpr-936494
ABSTRACT
OBJECTIVE To conduct a c omprehensive clinical evaluation method of Chinese patent medicine ,and to provide reference for rational clinical drug use. METHODS Taking the top 10 Chinese patent medicine injections for promoting blood circulation and removing stasis in Shandong province from 2016 to 2020 collected by the National Rational Drug Use Monitoring Network as an example ,the method combining health technology assessment with objective judgement analysis is used to construct the comprehensive evaluation index system ;based on evidence-based medical evidence and pharmacoeconomic model ,the safetyeffectiveness and economy of the drug were evaluated comprehensively ,and the scores were quantified. RESULTS & CONCLUSIONS The final scores of the 10 kinds of Chinese patent medicine injections were between 26 and 37 scores. Safflower yellow for injection scored the highest score in the treatment of cerebral infarction and angina pectoris of coronary heart disease , while Ginkgo diterpene lactone meglumine injection and Shuxuening injection had the highest scores in the treatment of coronary heart disease. The clinical comprehensive evaluation method of Chinese patent medicine based on evidence-based medical evidence and pharmacoeconomic model can clarify the comprehensive value of Chinese patent medicine in clinic ,promote rational drug use in clinic ,and provide basis for the next adjustment of medical insurance catalogue and essential medicine catalogue ,decision-making of centralized procurement of related drugs.

Full text: Available Index: WPRIM (Western Pacific) Type of study: Health technology assessment / Prognostic study Language: Chinese Journal: China Pharmacy Year: 2022 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Health technology assessment / Prognostic study Language: Chinese Journal: China Pharmacy Year: 2022 Type: Article